ट्रायल रडार AI | ||
|---|---|---|
क्लिनिकल ट्रायल NCT07348432 के लिए Insulin Dependent Diabetes Mellitus, पोषण और खाने के विकार, खाने का व्यवहार, टाइप 1 मधुमेह, स्व-प्रतिरक्षी रोग, अंतःस्रावी प्रणाली रोग वर्तमान में भर्ती जारी है। सभी विवरणों के लिए क्लिनिकल ट्रायल रडार कार्ड दृश्य और AI खोज उपकरण देखें, या यहाँ कुछ भी पूछें। | ||
एक परीक्षण फ़िल्टर मानदंडों से मेल खाता है
कार्ड दृश्य
The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes 106
चिकित्सा परीक्षण का विवरण मुख्य रूप से अंग्रेजी में उपलब्ध है। हालाँकि, ट्रायल रडार AI मदद कर सकता है! बस 'अध्ययन समझाएं' पर क्लिक करें और अपनी चुनी हुई भाषा में परीक्षण की जानकारी देखें और चर्चा करें।
क्लिनिकल ट्रायल NCT07348432 एक अवलोकनात्मक चिकित्सकीय अध्ययन है जो Insulin Dependent Diabetes Mellitus, पोषण और खाने के विकार, खाने का व्यवहार, टाइप 1 मधुमेह, स्व-प्रतिरक्षी रोग, अंतःस्रावी प्रणाली रोग से जुड़ा हुआ है। परीक्षण वर्तमान में भर्ती जारी चल रहा है। इसकी शुरुआत 29 जुलाई 2024 को हुई थी, और इसमें कुल 106 प्रतिभागियों के नामांकन की योजना है। मैकगिल विश्वविद्यालय इस परीक्षण का नेतृत्व कर रहे हैं और इसके 1 मई 2026 तक पूरा होने की उम्मीद है। ClinicalTrials.gov वेबसाइट पर यह जानकारी 16 जनवरी 2026 को अंतिम बार अपडेट की गई थी।
संक्षिप्त सारांश
Type 1 diabetes is an autoimmune health condition that requires daily injections of insulin. Insulin allows the body to use energy from carbohydrates in food. Disordered eating behaviours, like restricting food intake to lose body weight, are more common in women and people with type 1 diabetes, compared to those without because they must practice carbohydrate counting. Carbohydrate counting means identifying, measur...और दिखाएँ
विस्तृत विवरण
Introduction: Type 1 diabetes occurs when the pancreas cannot produce insulin and a person must be given insulin exogenously. Managing this health condition involves strict diet planning including carbohydrate counting (i.e. identifying and counting carbohydrates to match insulin dose). In addition, to high food management burden, frequent bodyweight monitoring, and weight gain related to insulin usage, makes people ...और दिखाएँ
आधिकारिक शीर्षक
The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes
स्वास्थ्य स्थितियां
Insulin Dependent Diabetes Mellitusपोषण और खाने के विकारखाने का व्यवहारटाइप 1 मधुमेहस्व-प्रतिरक्षी रोगअंतःस्रावी प्रणाली रोगप्रकाशन
इस नैदानिक परीक्षण के बारे में प्रकाशित वैज्ञानिक लेख और शोध पत्र:अन्य अध्ययन आईडी
- 23-07-045
NCT नंबर
अध्ययन प्रारंभ तिथि (वास्तविक)
2024-07-29
अंतिम अद्यतन प्रकाशित
2026-01-16
अध्ययन की समाप्ति तिथि (अनुमानित)
2026-05-01
नामांकन (अनुमानित)
106
अध्ययन प्रकार
अवलोकनात्मक
स्थिति
भर्ती जारी
प्रमुख शब्द
Automated Insulin Delivery
Disordered Eating Behaviours
Nutrition
Type 1 Diabetes
Disordered Eating Behaviours
Nutrition
Type 1 Diabetes
समूह/हस्तक्षेप
| प्रतिभागी समूह/शाखा | हस्तक्षेप/उपचार |
|---|---|
निर्दिष्ट नहीं | Automated Insulin Delivery (AID) Systems AID automatically adjusts insulin delivery by using continuously measured blood glucose levels. AID use will be determined through the initial questionnaire through the following questions:
Do you currently use the pump as an automated insulin delivery system (connected to a CGM with automated insulin adjustments)? Yes, a commercial AID with control IQ (Tandem) or SmartGuard (Medtronic) Yes, a non-commercial open-so...और दिखाएँ Carbohydrate Counting Inaccuracy Percentage Carbohydrate counting inaccuracy: will be determined by subtracting the estimated carbohydrates (by participant) by the actual amount of carbohydrate (through diet analysis) divided by the actual amount of carbohydrate, multiplied by 100, to determined the percentage. Estimated carbohydrate counts will be entered at each meal and snack by the participant in a daily log provided to the participant. Carbohydrate amount...और दिखाएँ |
प्राथमिक परिणाम माप
द्वितीयक परिणाम माप
| परिणाम माप | माप विवरण | समय सीमा |
|---|---|---|
Disordered Eating Behaviours | The primary outcome variable disordered eating behaviours will be measured through the Three Factor Eating Questionnaire-Revised 21 (TFEQ) in adults. The primary outcome for youth (12 to 17y) is the Child Three Factor Eating Questionnaire 17, which is an adapted questionnaire from the TFEQ.
TFEQ refers to current dietary practice and measures 3 different aspects of eating behaviour: cognitive dietary restraint (conscious restriction of food intake) score ranges from 6 to 24, uncontrolled eating (tendency to eat more than usual due to loss of control over intake accompanied by subjective feelings of hunger) score ranges from 9 to 36, and emotional eating (inability to resist emotional cues) score ranges from 6 to 24. Higher scores in the respective scales indicate greater level of restrained, uncontrolled, or emotional eating. | Collected at one time point per participant at the time of survey completion. The study has an observational, cross-sectional design from April 2024 to estimated May 2026. |
Diabetes Disordered Eating Behaviours | The Diabetes Eating Problem Survey (DEPS-R) is a 16-item questionnaire for youth and adults over the age of 12 years. It refers to disordered eating behaviours specific to people with type 1 diabetes. The score ranges from 0 to 80, with a higher score indicating higher risk of disordered eating. | Collected at one time point per participant at the time of survey completion. The study has an observational, cross-sectional design from April 2024 to estimated May 2026 |
Orthorexia Eating Behaviours | The Teruel Orthorexia Scale is a 17-item questionnaire, that is validated in both English and French. It measures 'healthy orthorexia' behaviours as well as behaviours related to 'orthorexia nervosa'. Healthy orthorexia describes individuals who have a high interest in healthy eating, but in a non-pathological dimension of orthorexia. This sub scales score ranges from 0 to 27. Orthorexia nervosa includes behaviours that are related to healthy eating that may cause malnutrition, emotional distress, and social impairment. This subscale ranges from 0 to 24. A higher score represents more orthorexia symptoms. | Collected at one time point per participant at the time of survey completion. The study has an observational, cross-sectional design from April 2024 to estimated May 2026 |
| परिणाम माप | माप विवरण | समय सीमा |
|---|---|---|
Glucose Time In Range (TIR) | Time in Range (TIR) (%): glucose TIR is the percentage of time that glucose levels are between 3.9 and 10.0 mmol/L. A higher TIR indicates improved glycemic levels. Guidelines recommend a TIR greater than 70% for most PwT1D. | Collected at one time point per participant at the time of survey completion. The study has an observational, cross-sectional design from April 2024 to estimated May 2026. |
Coefficient of Variation (CV) | Coefficient of Variation (CV) is determined by dividing the standard deviation of blood glucose levels over a 14-day period, by the total mean glucose and multiplying by 100 to obtain a percentage. This value reflects the variability of glucose levels. A higher CV value indicates more glycemic variability. | Collected at one time point per participant at the time of survey completion. The study has an observational, cross-sectional design from April 2024 to estimated May 2026. |
भागीदारी सहायक
पात्रता मानदंड
अध्ययन के लिए पात्र आयु
बच्चा, वयस्क, वृद्ध वयस्क
अध्ययन के लिए न्यूनतम आयु
12 Years
अध्ययन के लिए पात्र लिंग
सभी
स्वस्थ स्वयंसेवकों को स्वीकार करता है
हाँ
- 12 years of age or older
- Living in Canada
- Living with type 1 diabetes for more than 1 year
- Using at least 2 insulin injections per day or using an insulin pump
- Using current insulin delivery system for 3 months or more
- Are pregnant or currently are breastfeeding
- Don't speak French or English
- Does not have a smart phone (to download applications)
अध्ययन उत्तरदायी पक्ष
Anne-Sophie Brazeau, मुख्य अन्वेषक, Associate Professor, McGill University
अध्ययन केंद्रीय संपर्क
संपर्क: Courtney South, MSc, 705-527-4843, [email protected]
संपर्क: Anne-Sophie Brazeau, PhD, 514-398-7848, [email protected]
1 1 देशों में अध्ययन स्थान
Quebec
McGill University, Montreal, Quebec, H9X 3V9, Canada
Anne-Sophie Brazeau, PhD, संपर्क
भर्ती जारी